Peng Lei obtained his BSc degree in pharmacy from Wuhan University in June 2009. After that, he joined in WuXi AppTec and then in Chempartner , working as FTE for Merck and Abbott for three years. Then he joined in glmenthol, a small company which produces Menthol. Two years latter, he joined Suli Pharmaceutical Technology for process development of pharmaceutical APIs and intermediates. In October 2019, he joined the Chen Lab. His research interest is synthesis of NIR‐II dye and radionuclide theranostic drug.